Testing is one piece of reopening, but experts are still relying on the help of a vaccine to keep the public safe. Researchers are increasingly optimistic that scientists are getting closer to development even though we’re barely months into identifying and learning about the novel strain of SARS. Human and clinical trials are well underway, but just when they’ll be ready for manufacturing and distribution is another story. What is a realistic timeline and does one exist? We asked Dr. Vincent Silenzio an expert in urban and global public health at Rutgers University. To read the full story.
Recent Posts
- Grant Writing Mini Course – Registration Deadline Today!
- New Jersey coasts, lined with toxic facilities, don’t fare well in two new studies.
- Translational Science Competency-Based Assessment Pilot Test Sign Up
- As few as 2 cigarettes per day linked to 50% increased risk of heart disease: Study
- What You Need to Know About ‘Ozempic Face,’ According to Doctors.
Categories
- Community (2,404)
- Covid (993)
- CTO Events (6)
- News (3,046)
- Pilots (21)